|
The Inhibition of Intima Hyperplasia with Antisense Endothelin Receptor a Oligodeoxynucleotide (AS-ETA-ODN) in Rat Arterial Allograft
Views: | Article Submitted On: 09-03-2010 | Share This: |
Background : Transplant coronary artery disease remains a troublesome long term complication of heart transplantation .The character of GCAD is vascular narrowing resulting from intimal hyperplasia. The pathogenesis of intimal hyperplasia is thought to derive from an interation between immune and nonimmune factors ,leading to endothelial dysfunction and smooth muscle cells(SMCs) proliferation . Endothelin-1 (ET-1)is derived from vascular endothilium ,SMCs and macrophages .ET-1 has a wide range of biological and pathological functions . ET-1 stimulates constriction of SMCs and the proliferation of SMC . ET-1 induces the production of cytokines and growth factors such as endothelial growth factor,basic fibroblast growth factor and epiregulin .ET-1 also potentiates the effects of transforming growth factor-B and PDGF and interates with blood cells stimulating neutrophil adhesion and platelet agrregation .ET-1 ,predominantly via endothelin receptor A (ETA) ,promotes vasoconstriction ,cell growth ,cell adhesion and thrombosis ,thus ,ET-1 and ETA receptor is a pomising target for cardiovascular therapy . It has been demonstrated that ET-1 expression increased in the neointimal of coronary artery in allograft heart .However the role of ETA receptor in the pathogensis of GCAD is still unknown The study is to inverstigate changes of the expresssion of ETA in allograft carotid artery and blockade of ETA expression with antisense oligodeoxynuleutides of endothelin receptor A (AS-ETA- ODN) leading inhibition of intimal hyperplasia in the allograft carotid arteryPart I Transplant Artery Disease in An Rodent Model Objective: This study is to set up a arterial homeotransplant model . Method :Carotid artery of Wistar rat was transplanted into carotid artery